ID: ALA55587

Max Phase: Preclinical

Molecular Formula: C40H70N4O2

Molecular Weight: 639.03

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1CNCCCCCCNCCCCCCCCCCCCNCCCCCCNCc1ccccc1OC

Standard InChI:  InChI=1S/C40H70N4O2/c1-45-39-27-17-15-25-37(39)35-43-33-23-13-11-21-31-41-29-19-9-7-5-3-4-6-8-10-20-30-42-32-22-12-14-24-34-44-36-38-26-16-18-28-40(38)46-2/h15-18,25-28,41-44H,3-14,19-24,29-36H2,1-2H3

Standard InChI Key:  PMCCMEISWXQOME-UHFFFAOYSA-N

Associated Targets(Human)

Muscarinic acetylcholine receptor M2 10671 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Acetylcholine receptor 120 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M3 1154 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 639.03Molecular Weight (Monoisotopic): 638.5499AlogP: 8.78#Rotatable Bonds: 33
Polar Surface Area: 66.58Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 11.06CX LogP: 8.91CX LogD: -0.34
Aromatic Rings: 2Heavy Atoms: 46QED Weighted: 0.06Np Likeness Score: -0.19

References

1. Rosini M, Bixel MG, Marucci G, Budriesi R, Krauss M, Bolognesi ML, Minarini A, Tumiatti V, Hucho F, Melchiorre C..  (2002)  Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 2. Role of polymethylene chain lengths separating amine functions and of substituents on the terminal nitrogen atoms.,  45  (9): [PMID:11960498] [10.1021/jm011067f]
2. Bolognesi ML, Bixel MG, Marucci G, Bartolini M, Krauss M, Angeli P, Antonello A, Rosini M, Tumiatti V, Hucho F, Melchiorre C..  (2002)  Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure.,  45  (15): [PMID:12109912] [10.1021/jm020835f]
3. Minarini A, Zini M, Milelli A, Tumiatti V, Marchetti C, Nicolini B, Falconi M, Farruggia G, Cappadone C, Stefanelli C..  (2013)  Synthetic polyamines activating autophagy: effects on cancer cell death.,  67  [PMID:23887056] [10.1016/j.ejmech.2013.06.044]

Source